Fate Therapeutics Inc (NAS:FATE)
$ 3.76 0.1 (2.73%) Market Cap: 428.01 Mil Enterprise Value: 135.15 Mil PE Ratio: 0 PB Ratio: 1.01 GF Score: 58/100

Fate Therapeutics Inc at Bank of America NAPA Healthcare Conference Transcript

Jun 15, 2021 / 09:30PM GMT
Release Date Price: $86.79 (-3.53%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Good afternoon, everybody. Welcome to the continuation of the Bank of America Virtual NAPA conference. We hope to be live in NAPA again in the future. Our next presenting company is Fate Therapeutics. It's been a very busy several months for Fate, and we're looking forward to spending the next 48 minutes or so talking with management. Specifically from management with me this afternoon is Chief Executive Officer, Scott Wolchko; as well as CFO, Ed Dulac. Good afternoon, gentlemen. Thank you so much for joining us.

J. Scott Wolchko
Fate Therapeutics, Inc. - Founder, CEO, President & Director

Thank you. Thank you for having us.

Tazeen Ahmad;J. Scott Wolchko
BofA Securities, Research Division - VP;Fate

So let's start off maybe with a quick overview of the company, Scott, if that's okay. And then we can go into some of the details of events that have happened, and we can talk about what to look forward to for the rest of the year.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot